Firebrick Pharma Ltd has released a press release.
March 2025 Quarterly Activity Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Firebrick Pharma Limited on 6ix
Story so far
Earlier from Firebrick Pharma
- FRE secures Strategic Investment from Philippines Partner
- Appendix 4D & Half-Year Financial Report to 31 December 2024
- December 2024 Quarterly Activity Report & Appendix 4C
- Nasodine Retail Pharmacy Launch in Singapore
- Agreement Signed to Market Nasodine to HCPs in Singapore
Later from Firebrick Pharma
- Withdrawal of Share Placement
- Firebrick Closes Placement at $0.2 milliion
- June 2025 Quarterly Activity Report & Appendix 4C
- License Agreement for Singapore, Malaysia, Brunei, Mauritius
- Firebrick Secures $1.4 million via Placement
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma